ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,686Medicare Part D Prescriptions Filled, Including Refills

Rank: 36 out of 1155

$558K Total Retail Price of All Prescriptions

Rank: 29 out of 1155

421 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 421 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

19% of this provider’s 421 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 8,901 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
SIMVASTATIN 484 436 1 3
LISINOPRIL 353 311 2 1
HYDROCODONE-ACETAMINOPHEN 286 203 S3 3 4
FUROSEMIDE 280 232 4 8
AMLODIPINE BESYLATE 272 257 5 6
WARFARIN SODIUM 270 259 6 11
LEVOTHYROXINE SODIUM 268 238 7 2
PRAVASTATIN SODIUM 264 230 8 20
METFORMIN HCL 259 241 9 7
OMEPRAZOLE 240 197 10 5
METOPROLOL SUCCINATE 206 202 11 17
LOSARTAN POTASSIUM 196 182 12 18
ATORVASTATIN CALCIUM 176 152 13 12
CARVEDILOL 159 146 14 28
METOPROLOL TARTRATE 150 133 15 14
POTASSIUM CHLORIDE 148 117 16 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 143 117 17 26
MORPHINE SULFATE ER 137 98 S2 18 36
ZOLPIDEM TARTRATE 129 105 19 21
GABAPENTIN 126 93 20 15
ALENDRONATE SODIUM 121 116 21 25
TAMSULOSIN HCL 119 106 22 27
ALLOPURINOL 113 113 23 29
HYDROCHLOROTHIAZIDE 105 101 24 9
CITALOPRAM HBR 101 96 25 19
OXYCODONE-ACETAMINOPHEN 101 73 S2 25 45
TRAMADOL HCL 99 78 27 32
SERTRALINE HCL 94 82 28 24
PREDNISONE 87 43 29 40
NABUMETONE 82 61 30 150
DONEPEZIL HCL 78 78 31 41
DIGOXIN 68 51 32 54
ROPINIROLE HCL 67 49 33 94
ZETIA 67 56 33 129
CARBIDOPA-LEVODOPA 66 47 35 124
AMITRIPTYLINE HCL 66 43 R 35 42
ATENOLOL 65 58 37 10
ADVAIR DISKUS 62 50 38 35
LOSARTAN-HYDROCHLOROTHIAZIDE 59 57 39 65
SPIRIVA 58 54 40 49
CIPROFLOXACIN HCL 58 53 40 72
DILTIAZEM ER 56 51 42 141
FINASTERIDE 56 56 42 104
RANITIDINE HCL 55 49 44 33
TRAZODONE HCL 53 36 45 22
BENAZEPRIL HCL 53 44 45 85
ACTOS 52 52 47 167
METHADONE HCL 52 24 S2 47 50
OXYBUTYNIN CHLORIDE ER 52 52 47 130
CLOPIDOGREL 52 46 47 70
PROAIR HFA 51 36 51 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 18, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.